Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IMRN | US
-0.04
-1.99%
Healthcare
Biotechnology
30/09/2024
17/10/2024
1.97
2.02
2.04
1.96
Immuron Limited a biopharmaceutical company engages in the research development and commercialization of polyclonal antibodies in Australia Israel Canada the United States and internationally. The company operates through two segments Research and Development and Hyperimmune Products. It offers Travelan an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) that is in Phase III registration trial to reduce the risk of contracting travelers' diarrhea in the United States and Phase II field trial for Travelers' Diarrhea as well as acts as an anti-viral activity against SARS-CoV-2; and IMM-529 which is in Phase I/IIa clinical trial for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton Australia.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
109.7%1 month
89.5%3 months
69.5%6 months
75.9%-
-
1.47
0.01
0.01
0.77
1.37
-
-5.21M
11.22M
11.22M
-
-131.96
-
108.60
-42.92
1.26
0.18
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.93
Range1M
1.07
Range3M
1.07
Rel. volume
2.64
Price X volume
58.56K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
KTRA | KTRA | Biotechnology | 0.2154 | 11.99M | -6.31% | n/a | 0.00% |
DOMH | DOMH | Biotechnology | 1.88 | 11.80M | -3.09% | n/a | 7.66% |
BioRestorative Therapies Inc | BRTX | Biotechnology | 1.6815 | 11.64M | -2.80% | n/a | 0.77% |
Jaguar Health Inc | JAGX | Biotechnology | 1.23 | 11.37M | 0.00% | 0.26 | 176.14% |
Common Stock | ADXN | Biotechnology | 10.6 | 11.33M | 0.47% | n/a | 0.25% |
Evogene Ltd | EVGN | Biotechnology | 2.14 | 11.15M | -16.08% | n/a | 26.41% |
TransCode Therapeutics Inc. Common Stock | RNAZ | Biotechnology | 0.599 | 10.78M | -11.79% | 0.00 | 17.19% |
Sensei Biotherapeutics Inc | SNSE | Biotechnology | 0.4237 | 10.66M | -7.69% | n/a | 9.67% |
RedHill Biopharma Ltd | RDHL | Biotechnology | 8.205 | 10.51M | -3.36% | n/a | 65.80% |
Alterity Therapeutics Limited | ATHE | Biotechnology | 1.2 | 10.49M | -4.00% | n/a | 1.15% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.77 | 0.53 | Expensive |
Ent. to Revenue | 1.37 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 1.47 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 69.49 | 72.92 | Par |
Debt to Equity | 0.01 | -1.24 | Expensive |
Debt to Assets | 0.01 | 0.25 | Cheaper |
Market Cap | 11.22M | 3.78B | Emerging |